Long-Term Warfarin Use Tied to Increased Dementia Risk

Share this content:
Long-Term Warfarin Use Tied to Increased Dementia Risk
Long-Term Warfarin Use Tied to Increased Dementia Risk

FRIDAY, May 6, 2016 (HealthDay News) -- Patients with atrial fibrillation may have a heightened risk of developing dementia -- and the quality of their anticoagulation treatment may play a role, according to findings presented at the annual meeting of the Heart Rhythm Society, held from May 4 to 7 in San Francisco.

The findings are based on records from 10,537 patients who were on warfarin for atrial fibrillation or to prevent thromboembolism from other causes. Over six to eight years, 5.8 percent of the atrial fibrillation patients developed dementia, including Alzheimer's disease -- versus 1.6 percent of other warfarin patients.

After adjustment for age and health quality, the atrial fibrillation patients had more than double the risk of dementia than that of other patients. Compared with patients whose warfarin was in therapeutic range more than 75 percent of the time, those who were usually out of range had 2.5 to four times the odds of developing dementia.

T. Jared Bunch, M.D., the lead researcher on the study and cardiologist at Intermountain Medical Center in Murray, Utah, told HealthDay that the findings uncover two potential concerns: Patients with atrial fibrillation may face an increased risk of dementia, independent of warfarin use, but warfarin might also contribute to dementia if the doses are not optimal. "If people's levels of warfarin were erratic, their dementia risk was higher, whether they had atrial fibrillation or not," Bunch said.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »